Terry Sampson
Family · Winnsboro, TXNPI 1093079279
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 153 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Novo Nordisk at 44.2% of the total. Reporting peaked in 2021 at $1,080 and has fallen 95.9% since, to $44 in 2025.
Across 153 payments — averaging $15.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Bayer$308
- Lilly USA, LLC$253
- AstraZeneca$250
- Currax Pharmaceuticals LLC$168
- Genentech USA, Inc.$92
- plus $274 from 7 others
What the payments were for
- Food & beverage$2,412100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 73 | $1,065 |
| Bayer | 10 | $308 |
| Lilly USA, LLC | 13 | $253 |
| AstraZeneca | 16 | $250 |
| Currax Pharmaceuticals LLC | 16 | $168 |
| Genentech USA, Inc. | 7 | $92 |
| Exact Sciences | 5 | $78 |
| Phadia US Inc. | 4 | $67 |
| Boehringer Ingelheim | 4 | $52 |
| GSK | 2 | $36 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Corium, LLC | 1 | $14 |
| Intuitive Surgical | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,412 in reported general payments places this provider in the 80th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 13 | $10,091 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 41 | $1,110 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $1,069 |
| Gabapentin | 50 | $721 |
| Omeprazole | 49 | $486 |
| Potassium Chloride | 35 | $447 |
| Rosuvastatin Calcium | 29 | $414 |
| Azelastine Hcl | 11 | $394 |
| Quetiapine Fumarate | 16 | $374 |
| Olmesartan Medoxomil | 17 | $321 |
| Levothyroxine Sodium | 20 | $286 |
| Metoprolol Succinate | 13 | $274 |
| Pantoprazole Sodium | 34 | $239 |
| Atorvastatin Calcium | 51 | $236 |
| Doxycycline Hyclate | 22 | $230 |
Paid to pharmacies, not to this prescriber.
Other family in Winnsboro
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.